Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIO STOKER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   16.2% 12.6% 13.7% 4.4% 4.6% 3.5% 18.7% 18.7%   Credit score (0-100)   12 18 15 47 45 53 7 7   Credit rating   BB BB BB BBB BBB BBB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 114 45 116 116 116   Gross profit   6.0 6.2 -20.8 202 29.0 106 0.0 0.0   EBITDA   6.0 6.2 -20.8 106 29.0 106 0.0 0.0   EBIT   6.0 6.2 -20.8 106 29.0 106 0.0 0.0   Pre-tax profit (PTP)   -188.0 78.0 2.1 107.0 9.0 94.7 0.0 0.0   Net earnings   -192.0 76.9 2.1 114.0 12.0 102.3 0.0 0.0   Pre-tax profit without non-rec. items   -188 78.0 2.1 107 9.0 94.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   103 180 182 296 308 410 122 122   Interest-bearing liabilities   93.0 136 0.0 103 108 90.1 0.0 0.0   Balance sheet total (assets)   299 367 326 437 423 532 122 122   Net Debt   52.0 -135 -45.4 100 105 80.8 -122 -122     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 114 45 116 116 116   Net sales growth   0.0% 0.0% 0.0% 0.0% -60.5% 157.9% 0.0% 0.0%   Gross profit   6.0 6.2 -20.8 202 29.0 106 0.0 0.0   Gross profit growth   0.0% 4.1% 0.0% 0.0% -85.6% 264.1% -100.0% 0.0%   Employees   0 0 0       0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   299 367 326 437 423 532 122 122   Balance sheet change%   -35.0% 22.6% -11.1% 34.1% -3.2% 25.8% -77.1% 0.0%   Added value   6.0 6.2 -20.8 106.0 29.0 105.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 93.0% 64.4% 91.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 -1.0 1.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 93.0% 64.4% 91.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 93.0% 64.4% 91.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 52.5% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 100.0% 26.7% 88.1% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 100.0% 26.7% 88.1% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 93.9% 20.0% 81.6% 0.0% 0.0%   ROA %   -49.0% 24.8% 2.1% 28.6% 8.6% 22.1% 0.0% 0.0%   ROI %   -68.3% 32.3% 2.9% 37.5% 9.1% 23.1% 0.0% 0.0%   ROE %   -85.0% 54.3% 1.1% 47.7% 4.0% 28.5% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   34.4% 49.1% 55.9% 67.7% 72.8% 77.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 123.7% 255.6% 105.1% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 121.1% 248.9% 97.1% -105.2% -105.2%   Net int. bear. debt to EBITDA, %   866.7% -2,168.6% 218.8% 94.3% 362.1% 76.5% 0.0% 0.0%   Gearing %   90.3% 75.5% 0.0% 34.8% 35.1% 22.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.3% 4.0% 7.4% 3.9% 26.5% 11.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   1.4 1.5 0.8 0.2 0.2 0.4 0.0 0.0   Current Ratio   1.4 1.5 1.4 0.2 0.2 0.4 0.0 0.0   Cash and cash equivalent   41.0 271.4 45.4 3.0 3.0 9.4 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 104.3 136.9 209.8 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 21.9% 62.2% 37.4% 105.2% 105.2%   Net working capital   82.0 89.5 64.4 -116.0 -87.0 -78.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% -101.8% -193.3% -67.7% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 1,140 450 1,160 0 0   Added value / employee   0 0 0 1,060 290 1,056 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 1,060 290 1,056 0 0   EBIT / employee   0 0 0 1,060 290 1,056 0 0   Net earnings / employee   0 0 0 1,140 120 1,023 0 0